Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Previous | All Articles This Week | Next
This article originally posted 13 April, 2012 and appeared in  GLP-1 Receptor Agonist TherapyIssue 621

SPECIAL GLP-1 Test Your Knowledge Question #621

Hayley is a 45 year old female who has been diagnosed with type 2 diabetes mellitus for 2 years....

Advertisement

Her glycosylated hemoglobin (A1c) level is currently 7.9% with a regimen consisting of metformin 1000 mg twice daily, titrated from 500 mg twice daily 1 year ago at which time her A1c was 7.8%. Patient reports good adherence to both her drug regimen and recommended lifestyle modifications. Both you and Hayley are worried about weight gain as she has gained 9 kg since diagnosis, despite her best efforts. You decide to initiate a glucagon like peptide-1 (GLP-1) receptor agonist in addition to metformin.

Which are the main mechanisms of action of glucagon like peptide-1 (GLP-1) receptor agonists?

1.      Inhibits didpeptidyl peptidase-4

2.      Suppresses glucagon secretion

3.      Slows gastric emptying

4.      Blocks sodium glucose transporter in proximal tubule

5.      Increases secretion of insulin in the presence of elevated glucose

Please choose one answer:

a.    1 and 3

b.    2, 3 and 5

c.    2 and 4

d.    3, 4 and 5 

For the correct answer, please click here.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 April, 2012 and appeared in  GLP-1 Receptor Agonist TherapyIssue 621

Past five issues: Issue 677 | Diabetes Clinical Mastery Series Issue 136 | Issue 676 | Diabetes Clinical Mastery Series Issue 135 | Issue 675 |

2013 Most Popular Articles:

AACE Releases New Comprehensive Diabetes Management Algorithm
Posted April 25, 2013
Discovery Raises Hope for Type 1 Diabetes Reversal
Posted May 03, 2013
AACE - New Diabetes Guidelines Based on Tailored Approach
Posted May 09, 2013
AACE: Ralph A. DeFronzo, MD -- Diabetes Prevention Supports More Aggressive and Earlier Intervention
Posted May 09, 2013
Intermittent Fasting May Improve Diabetes and Reduce Cardiovascular Risk
Posted May 03, 2013
AACE – New Test Efficiently Detects Diabetic Neuropathy
Posted May 09, 2013
AACE: CAD Risk for Pre-Diabetes Similar to Diabetes
Posted May 09, 2013
Low-Glycemic Diet Seen to Reverse Diastolic Dysfunction of Diabetes
Posted May 03, 2013
New Pill in the Works for Type 1 Patients
Posted April 19, 2013
New Updated Hypoglycemia Classifications
Posted April 19, 2013

See more most popular…


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |
 
Diabetes In Control Advertisers
 
Cast Your Vote
What test do you use to screen for prediabetes?

Navigate Diabetes In Control



Search Articles On Diabetes In Control